Bernstein Insights

As public health officials focus on coronavirus containment strategies, a single question dominates: when will a vaccine be ready? That was the question we put to Ronny Gal, Bernstein’s senior research analyst specializing in Global Biotechnology and Pharmaceuticals. This episode also touches on the accelerated data sharing in the scientific community that’s fueling the quest for interim therapies. For more on our perspective, read our blogs http://bit.ly/COVID-19_blogs.Note to All Readers: The information contained here reflects the views of AllianceBernstein L.P. or its affiliates and sources it believes are reliable as of the date of this podcast. AllianceBernstein L.P. makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this podcast. This podcast is for informational pu